The Role of AGGF1 in the Classification and Evaluating Prognosis of Adult Septic Patients: An Observational Study
Wenqing Ji,Tiantian Wan,Fang Zhang,Shubin Guo,Xue Mei
DOI: https://doi.org/10.2147/idr.s447922
2024-03-21
Infection and Drug Resistance
Abstract:Wenqing Ji, &ast Tiantian Wan, &ast Fang Zhang, Shubin Guo, Xue Mei Department of Emergency Medicine, Beijing Key Laboratory of Cardiopulmonary Cerebral Resuscitation, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, People's Republic of China &astThese authors contributed equally to this work Correspondence: Shubin Guo; Xue Mei, Department of Emergency Medicine, Beijing Key Laboratory of Cardiopulmonary Cerebral Resuscitation, Beijing Chao-Yang Hospital, Capital Medical University, 8 South Workers Stadium Road, Chaoyang District, Beijing, 100020, People's Republic of China, Tel +86-10-85231000, Email ; Purpose: Angiogenic factor with G patch and FHA domains 1 (AGGF1) is a crucial angiogenic factor that is involved in a variety of diseases and in the regulation of inflammatory responses. However, its role in sepsis is poorly understood. We have investigated the role of AGGF1 in the classification and prognostic evaluation of adult septic patients in a clinical context. Patients and Methods: A total of 126 septic patients who visited the Emergency Department of Beijing Chao-Yang Hospital and 76 non-sepsis patients visiting the Physical Examination Center of Beijing Chao-Yang Hospital were enrolled. AGGF1 levels in plasma were detected by enzyme-linked immunosorbent assay. Spearman correlation analysis was used to determine correlations between plasma AGGF1 and Sequential Organ Failure Assessment (SOFA) score, Acute Pathology and Chronic Health Evaluation II (APACHE II) score, procalcitonin and lactate. We evaluated the classification significance of AGGF1 in sepsis using receiver operating characteristic (ROC) curves. We also assessed the predictive significance of AGGF1 for 28-day mortality in sepsis using ROC curves and Kaplan–Meier analyses. Results: Plasma AGGF1 levels were higher in sepsis patients than in non-sepsis patients (P < 0.001). Among sepsis patients, plasma AGGF1 levels were higher in non-survivors than in survivors (P < 0.001). Increased plasma AGGF1 levels were positively correlated with SOFA score, APACHE II score, procalcitonin and lactate. Plasma AGGF1 levels could distinguish sepsis patients from non-sepsis patients (area under the curve [AUC] = 0.777). AGGF1 had a higher predictive value than SOFA score, APACHE II score, lactate, procalcitonin, and white blood cell count for 28-day mortality in patients with sepsis (AUC = 0.876). Furthermore, Kaplan–Meier analysis indicated that lower plasma AGGF1 levels were associated with lower 28-day mortality compared with higher plasma AGGF1 levels (log rank P < 0.001). Conclusion: AGGF1 is useful for the classification and evaluating prognosis of adult septic patients. Keywords: AGGF1, sepsis, classification, predictor Sepsis results from a dysregulated reaction to an infection and is associated with substantial morbidity and mortality. 1,2 A study has revealed that 29.5% of patients can develop sepsis on admission or during ICU stay. 3 Death occurs in more than 25–30% of sepsis patients and hospital mortality of patients with septic shock is about 40–60%. 4 Traditional blood culture methods are low-sensitivity, and they can delay the initial management of sepsis. 5 This is unfavorable for the early diagnosis and treatment of sepsis. Emerging biomarkers, including miRNA, cell-free DNA, and presepsin, are promising for improving the diagnosis and treatment of sepsis. 5 However, the search for sepsis biomarkers with increased diagnostic and prognostic utility and is ongoing. 5 Angiogenic factor with G patch and FHA domains 1 (AGGF1) was initially discovered as a susceptibility gene for the congenital vascular disease, Klippel–Trenaunay syndrome, and it encodes a potent angiogenic factor. 6 The pathophysiological process of sepsis is heavily influenced by the inflammatory response. 7 Accumulating evidence indicates AGGF1 to play diverse roles in various pathological processes, including inflammation, apoptosis, and autophagy. 8–10 Exogenous AGGF1 treatment improved behavior by reducing neuroinflammation and blood–brain barrier disruption after subarachnoid hemorrhage-induced brain injury in rats. 11 In addition, AGGF1 can enhance angiogenesis and reduce inflammatory responses, myocardial apoptosis, and myocardial cell death, resulting in a decreased infarct size after ischemia/reperfusion injury in mice. 9 Despite the established role of AGGF1 in inflammation, its effect on sepsis remains insufficiently investigated. In the present study, we assessed the classification and prognostic utility of AGGF1 in sepsis in an effort to improve the diagnosis and treatment of the disease. The present -Abstract Truncated-
pharmacology & pharmacy,infectious diseases